Search

Author/Creator Keystone, E.

71. THU0192 5-Year Results from the Rapid 1 Trial and Open-Label Extension: Long-Term Safety and Efficacy of Certolizumab Pegol in Combination with Methotrexate in the Treatment of Rheumatoid Arthritis. (23rd January 2014)

Authors:
Keystone, E.; Landewé, R.; van Vollenhoven, R.; Combe, B.; Strand, V.; Mease, P. J.; Shaughnessy, L.; VanLunen, B.; van der Heijde, D.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 72:Supplement 3(2013)
Page Start:
A228
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

72. THU0193 Response To Baricitinib at 4 Weeks Predicts Response at 12 and 24 Weeks in Patients with Rheumatoid Arthritis: Results from Two Phase 3 Studies. (15th July 2016)

Authors:
Weinblatt, M.; Taylor, P.; Tanaka, Y.; Keystone, E.; Schiff, M.; Fleischmann, R.; Yang, L.; Arora, V.; de Bono, S.; Holzkaemper, T.; Schlichting, D.; Takeuchi, T.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 75(2016)Supplement 2
Page Start:
255
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

73. THU0198 Baricitinib Effects on Lipid and NMR-Measured Lipoprotein Profiles in A Phase 3 Study in Patients with Rheumatoid Arthritis. (15th July 2016)

Authors:
Taylor, P.; Keystone, E.; Tanaka, Y.; van der Heijde, D.; Zhong, J.; Thanabalasundrum, S.; Ruotolo, G.; Schlichting, D.; Rooney, T.P.; Macias, W.L.; Zuckerman, S.; de Bono, S.; Weinblatt, M.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 75(2016)Supplement 2
Page Start:
257
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

74. THU0198 EFFICACY AND SAFETY OF FILGOTINIB FOR PATIENTS WITH RHEUMATOID ARTHRITIS WITH INADEQUATE RESPONSE TO METHOTREXATE: FINCH 1 52-WEEK RESULTS. (2nd June 2020)

Authors:
Combe, B.; Kivitz, A.; Tanaka, Y.; Van der Heijde, D.; Simon-Campos, J. A.; Baraf, H. S. B.; Kumar, U.; Matzkies, F.; Bartok, B.; Ye, L.; Guo, Y.; Tasset, C.; Sundy, J.; Jahreis, A.; Mozaffarian, N.; Landewé, R. B. M.; Bae, S. C.; Keystone, E.; Nash, P.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 79(2020)Supplement 1
Page Start:
320
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

75. THU0201 A pooled analysis of three tnf-Α inhibitor biosimilar studies in patients with rheumatoid arthritis comparing radiographic progression by disease activity states. (12th June 2018)

Authors:
Smolen, J.S.; Weinblatt, M.; Emery, P.; Keystone, E.; Genovese, M.; Myung, G.; Hong, E.; Baek, I.; Lee, S.; Ghil, J.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 77(2018)Supplement 2
Page Start:
319
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

76. THU0201 Weak Correlation between A Multi-Biomarker Disease Activity Score and Clinical Response with Baricitinib in A Phase 2b Study in Rheumatoid Arthritis. (15th July 2016)

Authors:
Fleischmann, R.; Genovese, M.; Keystone, E.; Weinblatt, M.; Rancourt, J.; Nantz, E.; Schlichting, D.; Zuckerman, S.; Macias, W.L.; Taylor, P.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 75(2016)Supplement 2
Page Start:
259
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

77. THU0209 Characterization of Changes in Lymphocyte Subsets in Baricitinib-Treated Patients with Rheumatoid Arthritis in A Phase 3 Study (RA-BEAM). (15th July 2016)

Authors:
Tanaka, Y.; Fleischmann, R.; Schiff, M.; Takeuchi, T.; Keystone, E.; Weinblatt, M.; Zuckerman, S.; Issa, M.; Thanabalasundrum, S.; Augendre-Ferrante, B.; de Bono, S.; Schlichting, D.; Rooney, T.P.; Macias, W.L.; Taylor, P.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 75(2016)Supplement 2
Page Start:
262
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

78. THU0224 Randomized Double-Blind Comparative Effectiveness in RA Patients with Active Disease Despite Methotrexate (MTX): A Comparison of Conventional Disease-Modifying Anti-Rheumatic Drugs with a Biological. (23rd January 2014)

Authors:
O'Dell, J. R.; Mikuls, T. R.; Taylor, T.; Ahluwalia, V.; Brophy, M.; Warren, S.; Lew, R.; Phibbs, C.; Anis, A. H.; Cannella, A. C.; Kunkel, G. A.; Keystone, E.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 72:Supplement 3(2013)
Page Start:
A240
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

79. THU0226 Baricitinib Effects on Serum Cholesterol and Circulating Lipid Particles in a Phase 2B Study in Patients with Rheumatoid Arthritis. (23rd January 2014)

Authors:
Kremer, J.; Genovese, M. C.; Keystone, E.; Taylor, P.; Zuckerman, S. H.; Schlichting, D. E.; Beattie, S. D.; Macias, W. L.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 72:Supplement 3(2013)
Page Start:
A241
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

80. THU0228 Tofacitinib, an Oral Janus Kinase Inhibitor: Post-HOC Analyses of Efficacy and Safety of Monotherapy Versus Combination Therapy in a Phase 3 Rheumatoid Arthritis Population. (23rd January 2014)

Authors:
Keystone, E.; Fleischmann, R.; van Vollenhoven, R.; Kremer, J.; Gruben, D.; Bradley, J.; Riese, R.; Mebus, C.; Wallenstein, G.; Zwillich, S. H.; Benda, B.; Krishnaswami, S.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 72:Supplement 3(2013)
Page Start:
A242
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗